Zobrazeno 1 - 1
of 1
pro vyhledávání: '"D. Coefic"'
Autor:
E. Luporsi, Corina Oprea, C. Platini, Dominique Dramais, D. Coefic, Thomas Bachelot, D. Perol, Jocelyne Provencal, R. Ferri-Dessens, A. Bajard
Publikováno v:
Journal of Clinical Oncology. 26:1049-1049
1049 Background: In MBC, XT improves time to progression and overall survival (OS) vs docetaxel alone (O'Shaughnessy, 2002) and first-line capecitabine + paclitaxel shows similar efficacy to epirubicin + paclitaxel (Luck, 2007). The ERASME-4 and CAPE